Kolkata : CORONA Remedies Private Limited (CORONA) has entered into an agreement with Ferring Pharmaceuticals Pvt. Ltd. (Ferring), a subsidiary of Switzerland-based global biopharmaceuticals company Ferring Pharmaceuticals, to commercialize unique and innovative products in the field of Maternal Health & Urology.
The collaboration between CORONA and Ferring will cater to patients across India with innovative products including a few global brands to address the unmet therapeutic needs in maternal health and urology.
“We are delighted to
partner with Ferring, a research-driven, specialty biopharmaceutical group to
bring world-class medicines to patients in India. This partnership is in sync
with our purpose and commitment of #GoodHealthForAll,” said (Nirav Mehta,
Promoter & Executive Director) of CORONA.
CORONA is among the leaders
in women's healthcare and has a strong presence in various therapies such as
anti-hypertensive, diabetes, neuropathy, hormones, pain management,
dermatology, bone health, anti-ulcerant, & nutritional supplements.
Ferring’s maternal health
products are acknowledged in many countries and backed by clinical studies with
proven efficacy and safety. The urology products are formulated in an
innovative dosage form based on Ferring’s new proprietary technology platform
that will offer great convenience to patients with over active bladder and
erectile dysfunction.
All the products are unique
in their class, having differentiated formulations and drug delivery systems
that offer therapeutic advantages along with patient compliance and
convenience. The estimated market size for the said products collectively is
Rs. 778.30 crore & growing by 27%.
The novel products will be
distributed by 1500+ authorized stockiests of CORONA Remedies across the
country.
No comments:
Post a Comment